Answers are grounded in this paper and cite their sources.
In available guidelines, multimodal follow-up after treatment with curative intent of colorectal cancer is widely recommended, but the exact content and intensity are highly controversial. International agreement on the optimal follow-up schedule is unlikely to be achieved on current evidence, and further research should refocus on individualized 'patient-driven' follow-up and new biomarkers.
No takes yet. Share an insight, caveat, or question.
Bastiaenen et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: